U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871604) titled 'Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis' on Oct. 06.
Brief Summary: This study aims to compare the tolerability and metabolic safety of three low-dose statin/ezetimibe combinations (rosuvastatin/ezetimibe 2.5/10 mg, atorvastatin/ezetimibe 5/10 mg, pitavastatin/ezetimibe 1/10 mg) in patients with minimal subclinical atherosclerosis identified by imaging studies (CCTA, CAG, or carotid sonography)
Study Start Date: Nov. 10
Study Type: INTERVENTIONAL
Condition:
Atherosclerosis Cardiovascular Disease
Intervention:
DRUG: Crezet 2.5/10mg
Participants ...